Abstract

Fibrosis is considered a complex form of tissue damage commonly present in the end stage of many diseases. It is also related to a high percentage of death, whose predominant characteristics are an excessive and abnormal deposition of fibroblasts and myofibroblasts -derived extracellular matrix (ECM) components. Epithelial-to-mesenchymal transition (EMT), a process in which epithelial cells gradually change to mesenchymal ones, is a major contributor in the pathogenesis of fibrosis. The key mediator of EMT is a multifunctional cytokine called transforming growth factor-β (TGF-β) that acts as the main inducer of the ECM assembly and remodeling through the phosphorylation of Smad2/3, which ultimately forms a complex with Smad4 and translocates into the nucleus. On the other hand, the bone morphogenic protein-7 (BMP-7), a member of the TGF family, reverses EMT by directly counteracting TGF-β induced Smad-dependent cell signaling. NLRP3 (NACHT, LRR, and PYD domains-containing protein 3), in turn, acts as cytosolic sensors of microbial and self-derived molecules and forms an immune complex called inflammasome in the context of inflammatory commitments. NLRP3 inflammasome assembly is triggered by extracellular ATP, reactive oxygen species (ROS), potassium efflux, calcium misbalance, and lysosome disruption. Due to its involvement in multiple diseases, NLRP3 has become one of the most studied pattern-recognition receptors (PRRs). Nevertheless, the role of NLRP3 in fibrosis development has not been completely elucidated. In this review, we described the relation of the previously mentioned fibrosis pathway with the NLRP3 inflammasome complex formation, especially EMT-related pathways. For now, it is suggested that the EMT happens independently from the oligomerization of the whole inflammasome complex, requiring just the presence of the NLRP3 receptor and the ASC protein to trigger the EMT events, and we will present different pieces of research that give controversial point of views.

Highlights

  • Inflammasome Activation in the Epithelial to Mesenchymal TransitionThe inflammatory response is triggered in an attempt to remove an aggressor agent and leads to the wound healing process as a result of reparative or reactive steps in different organs concomitant with the elimination of the agent

  • Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology

  • The anti-inflammatory cells, on the other hand, appear to exert the opposite effect, i.e., controlling the inflammatory process. This subpopulation is responsible for producing IL-10, IL-4, and transformation growth factor-β (TGF-β) [15], playing, a role in the clearance of apoptotic cells and the formation of wound healing, mainly due to the expression of transforming growth factor-β (TGF-β), it has not been shown that the presence of anti-inflammatory macrophages in the absence of an inflammatory context leads to the formation of fibrotic tissue

Read more

Summary

Inflammasome Activation in the Epithelial to Mesenchymal Transition

The inflammatory response is triggered in an attempt to remove an aggressor agent and leads to the wound healing process as a result of reparative or reactive steps in different organs concomitant with the elimination of the agent This agent can be a pathogen, in which the inflammatory response is initiated after the recognition of a PAMP (Pathogen Associated Molecular Pattern), or the agent can be an endogenous product, named DAMP (Damage Associated Molecular Pattern), both recognized by PRRs (Pattern Recognition Receptors), which are receptors of innate immune system [1]. This subpopulation is responsible for producing IL-10, IL-4, and transformation growth factor-β (TGF-β) [15], playing, a role in the clearance of apoptotic cells and the formation of wound healing, mainly due to the expression of TGF-β, it has not been shown that the presence of anti-inflammatory macrophages in the absence of an inflammatory context leads to the formation of fibrotic tissue

Epithelial to Mesenchymal Transition
Kidney International
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call